WhichPeps

Acetyl octapeptide-3

Synthetic cosmetic octapeptide

Topical cosmetic wrinkl…
Generic peptide vial illustrationAcetyl octapeptide-3
Evidence levelHuman evidence
Human evidenceLimited
Regulatory statusCosmetic; not approved injectable

What you need to know in 20 seconds

What is it?Synthetic cosmetic octapeptide
Research focusTopical cosmetic wrinkle research
Human evidenceHuman cosmetic studies of microneedle formulations containing acetyl octapeptide-3 report wrinkle/skin-quality improvements, but the studied products also contained other active ingredients.
Regulatory statusCosmetic ingredient rather than an approved injectable therapeutic.
Main limitationsThe independent effect size, injectable efficacy, or long-term therapeutic benefit of acetyl octapeptide-3 alone.
SafetySystemic/injectable safety is not established and should not be inferred from cosmetic topical use.
i
Human cosmetic studies of microneedle formulations containing acetyl octapeptide-3 report wrinkle/skin-quality improvements, but the studied products also contained other active ingredients.

What the evidence actually supports

  • ✓Phrase as 'formulations containing SNAP-8 have been studied' rather than 'SNAP-8 proven to reduce wrinkles'.
  • ✓Grade the formulation evidence separately from isolated-compound efficacy.

What is not established / key limitations

  • ×No clean standalone ingredient RCT identified in this pass.
  • ×The studies do not isolate acetyl octapeptide-3 as the sole active ingredient.

Selected study & evidence records

Dissolving microneedle anti-wrinkle patch containing acetyl octapeptide-3

2024 · Controlled split-face cosmetic clinical study · n=24

The multi-ingredient patch improved several wrinkle/skin parameters versus control.

Study detail → Primary source ↗

Bioactive peptide-loaded hyaluronic acid microneedle patches for aged skin

2019 · Monocentric clinical study of a multi-active cosmetic patch · n=Not stated in search extract

Fine lines/wrinkles decreased about 25.8%; hydration, density and dermal thickness also improved.

Study detail → Primary source ↗

Safety and unknowns

Systemic/injectable safety is not established and should not be inferred from cosmetic topical use.

Topical cosmetic exposure is the relevant evidence context; systemic/injectable safety is not established.

Technical details

Mechanism / biologyDesigned as a cosmetic peptide intended to influence SNARE-associated neurotransmitter-release pathways at the skin surface.
Route / formulation boundaryProduct-level effects from multi-active microneedle formulations cannot be attributed wholly to acetyl octapeptide-3.
Identity / data-quality noteUse the canonical compound identity and studied formulation when interpreting evidence.
Dosing evidence statusDosing research conclusion recorded. A human cosmetic study used a multi-ingredient microneedle product, so an isolated acetyl octapeptide-3 dose-response cannot be assigned.
Identifiers & alternate namesSNAP-8 · Snap 8

Evidence rule: WhichPeps keeps human, animal, laboratory, regulatory and product/formulation evidence distinct. Common names help people find the page; they do not change the underlying scientific identity.